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The development of fluorescent 
protein tracing vectors for 
multicolor imaging of clinically 
isolated Staphylococcus aureus
Fuminori Kato, Motoki Nakamura & Motoyuki Sugai
Recent advances in fluorescent protein technology provide a wide variety of biological imaging 
applications; however current tools for bio-imaging in the Gram-positive bacterium Staphylococcus 
aureus has necessitated further developments for fluorescence intensity and for a multicolor palette 
of fluorescent proteins. To enhance the expression of multicolor fluorescent proteins in clinical S. 
aureus strains, we developed new fluorescent protein expression vectors, containing the blaZ/sodp 
promoter consisting of the β-lactamase gene (blaZ) promoter and the ribosome binding site (RBS) of 
superoxide dismutase gene (sod). We found S. aureus-adapted GFP (GFPsa) driven by the blaZ/sodp 
promoter was highly expressed in the S. aureus laboratory strain RN4220, but not in the clinical strains, 
MW2 and N315, harboring the endogenous blaI gene, a repressor of the blaZ gene promoter. We 
therefore constructed a constitutively induced blaZ/sodp promoter (blaZ/sodp(Con)) by introducing 
substitution mutations into the BlaI binding motif, and this modification allowed enhanced expression 
of the multicolor GFP variants (GFPsa, EGFP, mEmerald, Citrine, Cerulean, and BFP) as well as codon-
optimized reef coral fluorescent proteins (mCherry and AmCyan) in the S. aureus clinical strains. These 
new fluorescent probes provide new tools to enhance expression of multicolor fluorescent proteins and 
facilitate clear visualization of clinical S. aureus strains.
Fluorescent proteins are widely used as biological markers that enable visualization of subcellular protein locali-
zation, gene expressions, protein-protein interactions, and in vivo monitoring of bacterial infection1–3. Currently 
available fluorescent proteins are primarily derived from either the green fluorescent protein (GFP) originating 
in the jellyfish Aequorea victoria4, 5, or reef coral fluorescent proteins (RCFP) derived from Discosoma sp5–7. The 
wild type A. victoria GFP exhibits poor fluorescent brightness in Escherichia coli and mammalian cell lines; and 
many of the wild type GFP have a strong tendency to be expressed as an insoluble protein, showing cytotoxicity 
in E. coli8, 9. To date, extensive studies have reported numerous types of A. victoria GFP variants that provide sig-
nificant improvements in brightness, protein solubility, stability, pH-sensitivity, and yield4, 5, 9. Further, numerous 
variants of GFP and RCFP with distinct colors have been engineered using a combination of random mutagenesis 
and directed evolution. This has enabled co-visualization of several proteins in a single cell, selective identification 
of particular cells in co-culture systems, and detection of protein-protein interactions based on a measurement of 
fluorescence resonance energy transfer (FRET)1–5.
Staphylococcus aureus is a low-GC Gram-positive bacterium that causes a variety of diseases, e.g., abscess, 
bullous impetigo, toxic shock syndrome, pneumonia, sepsis, and food poisoning. Multidrug-resistant strains 
such as methicillin-resistant S. aureus (MRSA) cause severe hospital-acquired infections such as pneumonia and 
sepsis; and the resistance makes the treatment increasingly difficult. The development of molecular genetic tools 
including gene deletion, controllable gene expression, and bio-imaging is essential for our understanding of the 
mechanisms underlying the pathogenesis of S. aureus infections10, 11. Currently, for bio-imaging numerous GFP 
and RCFP variants are commercially available from many distributors; however, these FPs were not optimized for 
less common bacterial strains (e.g., clinical strains of S. aureus). Bio-imaging tools based on fluorescent proteins 
have also been widely used in the studies of S. aureus to visualize subcellular proteins or for biofilm formation as 
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Figure 1. Replacement of RBS sequence and introduction of Cycle3 mutations into GFPmut3. (a) Sequence 
alignment of the blaZp and its derivative blaZ/sodp promoters. Blue bold face indicates the surrounding 
sequence containing RBS derived from the sod gene. Underlined sequences indicate −35 and −10 elements of 
the blaZ promoter. Double underlines indicate the RBS sequence. Initiation codons are shown in uppercase. 
(b) The fluorescing colonies were photographed under UV excitation. S. aureus RN4220 containing pS1GFP, 
pFK51, and pFK52 were grown on TSB agar plate containing chloramphenicol. (c) The fluorescent intensities 
of GFPmut3b, and GFPsa in S. aureus RN4220. Cell homogenate of S. aureus containing pS1GFP, pFKS1 
and pFK52 was prepared and the fluorescent intensities at 513 nm were measured with a microplate reader, 
λex = 490 nm. The data represent mean values ± standard deviation. (d) The expression efficiency of pS1GFP, 
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well as to establish a S. aureus infection model using fluorescent proteins, in which optimization of codon usage 
and replacement of the region surrounding the ribosome binding sequence (RBS) have been reported to enhance 
the expression of the fluorescent proteins in S. aureus12–16. However, the current methods often entail several 
limitations as to color palette and its brightness and therefore necessitated the development of new fluorescent 
vectors that can efficiently enhance fluorescence intensity and the multicolor palette in S. aureus strains. Many 
proteins are generally difficult to highly express in heterologous host organisms. In E. coli, extensive research has 
established many different types of promoters and a great number of engineered laboratory strains for heterol-
ogous protein production17. However, a well-established method for the heterologous protein expression is still 
lacking in S. aureus, much less clinically isolated strains. Previous studies have focused on the β-lactamase gene 
(blaZ) promoter PblaZ for the gfp expression in S. aureus. Notably, the GFPmut2 was constitutively expressed in 
the laboratory strain RN422018–20. This study therefore developed fluorescent protein expression vectors with the 
PblaZ promoter to highly express GFP and RCFP variants in clinically isolated S. aureus.
Here, we describe novel fluorescent protein expression vectors, which were shown to exhibit greater fluores-
cence intensity in clinical S. aureus strains. To improve the expression of an exogenous fluorescent protein in S. 
aureus clinical strains, we used the blaZ/sodp(Con) promoter and codon-optimized fluorescent protein genes, 
and showed that the fluorescence intensity in the series of GFP and RCFP variants were significantly enhanced 
in the clinical strains. These new tools efficiently expressing fluorescent proteins in clinical S. aureus strains are 
valuable for understanding the pathogenic mechanism of S. aureus.
Results
Adaptation of the green fluorescent protein to S. aureus. We aimed to develop fluorescent pro-
tein expression vectors that can produce sufficient fluorescence intensity to visually identify fluorescing colonies 
of S. aureus on agar plates with the naked eye. S. aureus strain RN4220 colonies containing pS1GFP in which 
GFPmut3b was expressed under the control of the β-lactamase gene (blaZ) promoter exhibited faint fluorescence 
on TSB agar plates (Fig. 1b). When we replaced the 13-bp sequence containing RBS sequence of the blaZ gene 
with the corresponding region of the superoxide dismutase gene (sod) (Fig. 1a) that has been reported to enhance 
the expression of fluorescent protein in S. aureus13, the fluorescent activity of the colonies expressing GFPmut3b 
was significantly improved on the agar plates (Fig. 1b). Further, the fluorescence intensity increased by an approx-
imately 10-fold using the microplate assay reader (Fig. 1c). The high expression of GFPmut3b was confirmed as 
a major protein band corresponding to its molecular weight, 26.8 kDa, in SDS-PAGE (Fig. 1d). Although the 
GFPmut3b is one of the faster folding GFP variants that has been optimized for bacteria and has minimal toxic-
ity21, overexpression of GFPmut3b in S. aureus showed adverse effects such as cell growth inhibition, producing 
smaller colonies, and frequent co-occurrence of larger colonies exhibiting no fluorescence signal (Fig. S1a). To 
overcome these adverse effects, GFPmut3b was modified by introducing Cycle3 mutations (F99S/M153T/V163A) 
that are known to improve the solubility and reduce the toxicity9, 22, yielding S. aureus-adapted GFPmut3b, GFPsa 
(S65G/S72A/F99S/M153T/V163A). As a result, the mutations antagonized the appearance of non-fluorescent 
colonies and maintained high levels of the fluorescent intensity (Figs 1b,c and S1b) and GFPsa expression (Fig. 1d) 
without affecting its excitation and emission wavelengths (Fig. 1e,f). Further, confocal laser scanning microscopic 
analysis revealed that almost all of S. aureus cells expressed GFPsa protein and were clearly visualized (Fig. 1g).
Introducing suppressor mutations into the blaZ gene promoter. S. aureus-adapted GFPsa demon-
strated higher expression under the control of the hybrid blaZ/sodp promoter in laboratory strain RN4220. 
However, in clinical strains, MW2 and N315, with the same vector, the expression of GFPsa was very low, and the 
fluorescence intensity was poor (Fig. 2b,c,d). BlaZ plasmid is prevalent in clinical strains23, 24, and the blaIRZ gene 
operon is natively present on a plasmid in both clinical strains, MW2 and N315, but not in RN422025–27. The BlaI 
and MecI specifically bind to the same dyad symmetry (TACA/TGTA) sequence and repress the blaZ promoter 
activity (Fig. 2a)28. To minimize the possible negative effect by the endogenous BlaI/MecI on the blaZ/sodp pro-
moter activity, we introduced suppressor mutations into the BlaI/MecI binding motif (TACA/TGTA), yielding a 
constitutively induced blaZ/sodp(Con) promoter (Fig. 2a). As a consequence, GFPsa expression was significantly 
elevated, and the resulting fluorescence intensity was highly improved in both N315 and MW2, whereas the 
fluorescence intensity was slightly reduced in strain RN4220, compared with the parental sequence (Fig. 2b,c,d). 
Taken together, the data demonstrated the modified blaZ/sodp promoter, (blaZ/sodp(Con)) can effectively 
enhance the expression of GFPsa in S. aureus clinical strains.
Expression of multicolor GFP variants in clinical strains. A. victoria GFP and its variants contribute 
to multicolor imaging with spectral profiles ranging in color from blue to yellow, and have been engineered by 
site-directed mutagenesis29–34. Using GFPsa as the standard, we next constructed these GFP color variants (EGFP, 
pFK51, and pFK52 in S. aureus RN4220. SDS-PAGE and Western blot analysis show the relative quantities of 
the GFP in the whole cell lysates. The Western blot gel was cropped and the full-length image is included in 
Supplemental Fig. 5(a). (e) Excitation and (f) Emission spectra for GFPmut3b and GFPsa in S. aureus RN4220. 
Each spectrum was normalized to a maximum value of 1. Excitation spectra were recorded with emission at 
540 nm. Emission spectra were recorded with excitation at 460 nm. GFPmut3b and GFPsa were depicted by a 
solid line and dotted line, respectively. (g) S. aureus RN4220 containing pMK4blaZ/sodpGFPsa (pFK52) was 
grown on TSB containing chloramphenicol and visualized using an FV1000 confocal scanning laser microscope 
(Olympus). Panels show (1) DAPI, (2) GFP, (3) overlay of DAPI and GFP images, (4) differential interference 
contrast (DIC), (5) overlay of DAPI, GFP, and DIC images.
www.nature.com/scientificreports/
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Figure 2. Site-directed mutagenesis into the BlaI/MecI binding sequence. (a) Sequence alignment of the 
blaZ/sodp and its constitutively induced blaZ/sodp(Con) promoter region. Asterisks indicate the sequence 
exchanged by site-directed mutagenesis. Bold face indicates the BlaI/MecI binding motif (TACA/TGTA) 
within the larger palindromes, the R1 dyad and Z dyad are indicated by arrows. Up arrows with the tip to 
right indicates the transcription initiation site. Underlined sequences indicate −35 and −10 elements. Double 
underline indicates the RBS sequence. Initiation codons are shown in uppercase. (b) The fluorescing colonies 
were photographed under UV excitation. S. aureus RN4220, MW2 and N315 containing either pFK52, 
or pFK54 were grown on TSB agar plate containing chloramphenicol. (c) The comparison of fluorescence 
intensity among S. aureus strain RN4220, MW2, and N315 containing either pFK52, or pFK54. The fluorescent 
intensities at 513 nm were measured with a microplate reader, λex = 490 nm. The data represent mean 
values ± standard deviation. (d) The comparison of GFPsa expression efficiency among S. aureus strain RN4220, 
MW2, and N315 containing either pFK52, or pFK54. SDS-PAGE and Western blot analysis show the relative 
quantities of GFPsa in the whole cell lysates. The arrow indicates the position of GFPsa in gel. The Western blot 
gel was cropped and the full-length image is included in Supplemental Fig. 5(b).
www.nature.com/scientificreports/
5Scientific RepoRts | 7: 2865  | DOI:10.1038/s41598-017-02930-7
mEmerald, Citrine, Cerulean, and BFP) using amino acid substitutions considering the codon usage patterns in S. 
aureus. Since several BFP variants were engineered using substitution of the T66H mutation; we constructed three 
BFP variants, EBFP (F64L/S65T/Y66H/Y145F), 1EMF (F64L/Y66H/V163A), and P4–3E (F64L/Y66H/Y145F/
V163A) and evaluated which BFP variants would be more suitable for S. aureus MW2 and N315. Fluorescence 
assay showed that homogenates of P4-3E and EBFP exhibited somewhat greater fluorescence intensity than 1EMF 
when S. aureus MW2 were grown in TSB medium (Fig. S2a), while only S. aureus expressing P4-3E was visually 
identified as fluorescing colonies on agar plates by the naked eye (Fig. S2b). Each strain expressing the multicolor 
GFP variant exhibited sufficient fluorescence intensity to visually identify fluorescing colonies by the naked eye 
(Fig. 3a), and SDS-PAGE and Western blot analyses showed that like GFPsa all of these multicolor variants were 
expressed with high yield in S. aureus MW2 harboring the corresponding vectors with the blaZ/sodp(Con) pro-
moter (Fig. 3b,c). The multicolor GFP variant genes driven by the blaZ/sodp(Con) promoter also exhibited high 
fluorescence intensity in another clinical strain, N315 (Fig. S3a). Further, fluorescence excitation and emission 
spectrum analysis showed these strains expressing the multicolor GFP variants reflected the previously published 
spectrum profiles (Fig. S4). This data indicated that multicolor GFP variants were highly expressed in clinical 
strains MW2 and N315 with the blaZ/sodp(Con) promoter.
Codon optimization of AmCyan and mCherry for S. aureus. Like Aequorea GFP, reef coral fluorescent 
proteins (RCFP) and their variants also contribute to multicolor imaging with spectral profiles ranging in color 
from cyan to far red1, 5. We constructed the RCFP expression vectors for S. aureus clinical strains, in which the 
amCyan or mCherry gene was expressed under the control of the hybrid blaZ/sodp(Con) promoter. Unexpectedly, 
S. aureus expressing the commercially available amCyan or mCherry gene formed faintly fluorescent colonies 
on agar plates (Fig. 4a), we therefore optimized the codon usage of amCyan and mCherry genes by replacing 
rare GC- rich codons with AT-rich ones. As a consequence, the codon-optimized AmCyan (AmCyan(S.a)) and 
mCherry (mCherry(S.a)) exhibited sufficient fluorescence intensity to visually identify fluorescing colonies on 
agar plates by the naked eye (Fig. 4a), and the corresponding proteins were confirmed to their molecular weights, 
25.2 kDa and 26.7 kDa, respectively (Fig. 4b) and detected by Western blot (Fig. 4c). The fluorescence assay shows 
the codon adapted genes resulted in increased fluorescence intensity of AmCyan and mCherry (Fig. 4d,e). The 
amCyan and mCherry genes driven by the blaZ/sodp(Con) promoter also exhibited a significant fluorescence 
intensity in strain N315 (Fig. S3b). Further, fluorescence excitation and emission spectrum analysis showed 
these strains expressing AmCyan or mCherry reflected previously published spectrum profiles (Fig. S4). Taken 
together, the expression of AmCyan and mCherry were significantly improved in S. aureus clinical strains.
Figure 3. Detection of multicolor GFP variants in the clinical strain, MW2. (a) The fluorescing colonies were 
photographed using UV excitation. S. aureus strain MW2 expressing multicolor GFP variants (GFPsa, EGFP, 
mEmerald, Citrine, Cerulean, and BFP) were grown on TSB agar plate containing chloramphenicol. (b) The 
whole cell lysates of S. aureus MW2 expressing multicolor variants used for SDS-PAGE and Western blot 
analysis were photographed under UV excitation. (c) The comparison of expression efficiency among multicolor 
GFP variants in S. aureus strain MW2. SDS-PAGE and Western blot analysis show the relative quantities of the 
multicolor GFP variants in the whole cell lysates. The arrow indicates the position of GFP variants in gel. The 
Western blot gel was cropped and the full-length image is included in Supplemental Fig. 5(c).
www.nature.com/scientificreports/
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Identification of S. aureus cells expressing a specific fluorescent protein in co-culture sys-
tems. We next aimed to discriminate S. aureus cells expressing a specific fluorescent protein from the 
co-existence of bacteria expressing different fluorescent proteins in a co-culture experiment. Confocal laser scan-
ning microscopic analysis revealed that each S. aureus clinical strain expressing different fluorescent proteins 
was selectively detected in the co-culture system in which Cerulean, Citrine, and mCherry(S.a) were differently 
expressed in the strain N315, TY3435, and MW2, respectively (Fig. 5a). Further, S. aureus N315 cells expressing 
mCheery(S.a) were clearly distinguished from E. coli DH5α cells expressing EGFP (Fig. 5b). These results demon-
strated that our fluorescent protein expression vectors have the potential to sensitively detect particular S. aureus 
cells in co-culture with different strains or other bacteria.
Discussion
In this study, we developed new fluorescent protein vectors to express a bright fluorescence intensity enough to 
visually identify fluorescent colonies of S. aureus macroscopically on agar plates. Practically available high-level 
expression of fluorescent protein has not been achieved in previous studies in which fluorescent proteins were 
detected only with fluorescence microscopy10–14. Our findings provide new applications to enhance the expression 
Figure 4. Codon usage optimization of the amCyan and mCherry genes. (a) The fluorescing colonies were 
photographed under UV excitation. S. aureus strain MW2 containing pKAT (control), pFK62 (AmCyan), 
pFK64 (AmCyan(S.a)), pFK63 (mCherry), and pFK65 (mCherry(S.a)) were grown on TSB agar plates 
containing chloramphenicol. (b) SDS-PAGE analysis showed the relative quantities of AmCyan and mCherry 
in the whole cell lysates. Arrows indicate the position of AmCyan and mCherry in gel. (c) Western blot analysis 
of AmCyan or mCherry in the whole cell lysates. The Western blot gels were cropped and the full-length 
image are included in Supplemental Fig. 5(d). The comparison of fluorescent intensities of pKAT (control), 
pFK62 (AmCyan), and pFK64 (AmCyan(S.a)) in S. aureus MW2. The fluorescent intensities at 489 nm were 
measured with a microplate reader, λex = 458 nm. The data represent mean values ± standard deviation. (e) The 
comparison of fluorescent intensities of pKAT (control), pFK63 (mCherry), and pFK65 (mChaerry(S.a)) in S. 
aureus MW2. The fluorescent intensities at 610 nm were measured with a microplate reader, λex = 586 nm. The 
data represent mean values ± standard deviation.
www.nature.com/scientificreports/
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Figure 5. Confocal laser microscopic analysis in co-culture systems. (a) Co-culture of three clinically isolated 
S. aureus strains. S. aureus strain N315 containing pFK60 (Cerulean), strain TY34 containing pFK56 (Citrine), 
and strain MW2 containing pFK65 (mCherry(S.a)) were co-cultured in BHI broth. Panels show (1) Cerulean 
(N315), (2) Citrine (TY34), (3) mCherry(S.a) (MW2), (4) overlay of Cerulean, Citrine, and mCherry images, 
(5) DIC, (6) overlay of Cerulean, Citrine, mCherry, and DIC images. (b) Co-culture of S. aureus with E. coli. S. 
aureus N315 containing pFK65 (mCherry(S.a)) and E. coli DH5α containing pFK55 (EGFP) were co-cultured 
in BHI broth. Panels show (1) DAPI, (2) EGFP, (3) mCherry(S.a), (4) DIC, (5) overlay of DAPI and DIC images, 
and (6) overlay of EGFP, mCherry(S.a), and DIC images.
www.nature.com/scientificreports/
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of multicolor GFP variants and would allow us to sensitively detect particular S. aureus cells in bacterial popula-
tions and in animal infection models.
To enhance fluorescent brightness, we replaced the sequence from the Shine-Dalgarno (SD) sequence to the 
start codon with sod that was previously reported with the sod RBS to lead to the highest fluorescence intensity 
with the sarA promoter13. Consequentially, we not only modified the SD sequence of blaZ gene to an optimal 
SD sequence (AGGAGG), but also altered the distance from the SD sequence to the start codon. The distance 
between the RBS and the start codon is also known to affect the efficiency of translation initiation36. Our results 
support the concept that the improvement of the sequence from the SD sequence to the start codon sequence 
significantly enhances the expression of the GFP variant, although the exact mechanism responsible for this effect 
remains unclear (Fig. 1b). However, recent studies suggest the interaction among the RBS, the initiation codon, 
the 5′-coding region in translation initiation, and RNA secondary structure at the 5′ terminus affects the protein 
expression in bacteria37, 38. Therefore, the enhancement of GFP production may be accounted for by the decrease 
of free fold energy of the 5′ end of mRNA transcripts.
At the beginning of this study, we evaluated GFPsa expression vectors with the blaZ/sodp promoter in a lab-
oratory strain, RN4220. This strain is easily genetically manipulated; however, it carries a number of genetic 
mutations that may affect the virulence of the strain20, 27. Like RN4220, laboratory strains may not be suitable for 
the evaluation of pathogenesis, because laboratory strains often lack important pathophysiological characters39. 
Hence, clinical strains should be used to properly evaluate the pathogenesis and virulence of S. aureus. S. aureus 
harboring the bla gene locus appeared in the 1940s after the introduction of penicillin; and at present, most clini-
cal isolates carry the blaIRZ gene on plasmids or on the chromosome23, 40, 41. Because the GFPsa expression driven 
by the blaZ/sodp promoter was not detectable in S. aureus clinical strains, MW2 and N315 (Fig. 2), we hypoth-
esized the endogenous BlaI may inhibit the transcription of the blaZ/sodp promoter in trans; and we therefore 
generated the constitutively induced blaZ/sodp(Con) promoter to overcome the limitation of the clinical strains. 
The blaZ/sodp(Con) promoter can be adapted to enable expression of not only fluorescent proteins but also vari-
ous exogenous proteins (toxins) from clinical S. aureus strains.
Codon optimization frequently plays a key role in exogenous protein expression37, 42. The GC contents of 
human codon-optimized amCyan and mCherry are 46.8% and 62.5%, respectively, showing strong preferences for 
G + C at the third codon position is distinct from the codon usage patterns in S. aureus with 33.5% GC content. 
Exchanging the 92 nucleotides of amCyan gene and 76 nucleotides of mCherry gene, respectively, both fluores-
cence intensities were significantly improved overcoming the codon usage bias in S. aureus. However, SDS-PAGE 
analysis showed the level of RCFPs production did not reach the level of GFP variants (Figs 3c and 4b). These 
results suggest the possibility that further investigation with these vectors could improve the expression level of 
RCFPs by further adapting of codon usage or decreasing the free folding energy of the initial 5′-coding region.
In summary, we have developed new multicolor fluorescent protein vectors that efficiently enhance fluores-
cence intensity in S. aureus clinical strains where the greater fluorescence intensity of multicolor fluorescent 
proteins may facilitate clear visualization of S. aureus clinical strains. Ultimately, these findings may help in better 
understanding the pathogenic mechanisms of S. aureus.
Methods
Bacterial strains, plasmids and growth conditions. The bacterial strains and plasmids used 
in this study are in Table 1. S. aureus and E. coli were cultured at 37 °C with shaking at 140 rpm in test tube 
(25 mm × 150 mm) containing 3 ml of trypticase soy broth (TSB) (Becton, Dickinson and Company) or 3 ml of 
lysogeny broth (5 g yeast extract, 10 g polypeptone, 10 g NaCl per liter; pH 7.2), respectively. Ampicillin (Amp, 
100 µg/ml) and chloramphenicol (Cp, 10 µg/ml) were added to the medium if necessary. The plasmids encoding 
AmCyan or mCherry were purchased from Clontech, TaKaRa Bio Inc., Japan.
Improvement of GFP expression vector using site-directed mutagenesis. To increase expression 
of fluorescent proteins in S. aureus clinical strains, we improved a GFP expression vector based on pS1GFP car-
rying GFPmut3b gene (a kind gift from Prof. M. Krönke)19. The hybrid blaZ/sodp promoter was constructed 
by replacing the sequence containing the RBS in the blaZ gene in the sod gene with blaZPR and GFP-F primers 
using the inverse PCR method with KOD Plus Neo DNA polymerase (TOYOBO, Japan). The PCR product was 
phosphorylated with T4 Polynucleotide Kinase (TaKaRa Bio Inc, Japan), and circularized by self-ligation with 
Ligation high Ver.2 (TOYOBO, Japan); and then the circular DNA was transformed into E. coli DH5α. Plasmid 
DNA was extracted from the transformed E. coli DH5α using FastGeneTM Plasmid Mini Kit (Nippon Genetics 
Co., Ltd. Japan) and the resultant plasmid was verified using ABI 3130 DNA sequencer (Applied Biosystems). To 
express the fluorescent protein in S. aureus clinical strains, the substitution of the repressor BlaI/MecI binding 
motif (TACA/TGTA) was performed with the blaZ-mutF and blaZ-mutR primers using inverse PCR as above, 
yielding the constitutively induced blaZ/sodp(Con) promoter.
Construction of the multicolor GFP variants using amino acid substitution. Amino acid substi-
tution was performed using inverse PCR with pMK4blaZ/sodp(Con)GFPmut3b (pFK53) as the initial template 
with the KOD Plus Neo DNA polymerase (TOYOBO, Japan). The primers described in Table 2 were used to con-
struct the GFP variants (Table 3). The resulting plasmids were confirmed using DNA sequencing.
Construction of codon-optimized RCFP expression vectors. The amCyan and mCherry genes were 
combined with the hybrid blaZ/sodp(Con) promoter using overlap extension PCR and cloned into the pKAT 
vector43. Plasmid pKAT derived from pND5044 is an E. coli-S. aureus shuttle vector containing the replication 
origins of pUB110 (S. aureus) and the pUC19 (E. coli) lacZ(α) gene from pUC19. This enables a simple blue-white 
screening for clones in E. coli, and enables the cat gene conferring resistance to chloramphenicol in both E. coli 
www.nature.com/scientificreports/
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and S. aureus. All restriction enzyme sites in the multiple cloning site (MCS) located in the lacZ(α) gene can 
be used for cloning into pKAT. In the first PCR, the hybrid blaZ/sodp(Con) promoter region, amCyan gene, 
and mCherry gene were amplified from pFK53, pAmCyan (Clontech, TaKaRa Bio Inc., Japan), and pmCherry 
(Clontech, TaKaRa Bio Inc., Japan) with the following primer sets (AmCyan: blaZp-F and blaZPR-Cyan and 
blaZP-CyanF and pUC-RH; mCherry: blaZp-F and blaZPR-Cherry and blaZP-mCherryF and pUC-RH), respec-
tively. The second PCR was performed with the mixture of two PCR fragments as the template using the primer 
set (blaZp-F and pUC-RH). The resulting PCR products were digested with HindIII and cloned into the same site 
in pKAT. Codon optimization was then repeatedly performed using inverse PCR as mentioned above with the 
primers described in Table 2 that were designed to optimize the codon usage of amCyan and mCherry gene using 
the Kazusa Codon Usage Database (http://www.kazusa.or.jp/codon/). The DNA sequences of codon-optimized 
amCyan and mCherry genes have been submitted to the GenBank and are available under accession numbers 
LC088723 (amCyan) and LC88724 (mCherry).
Transformation of S. aureus and quantification of fluorescence intensity. In brief, S. aureus was 
individually transformed using electroporation as described previously45. Each plasmid was first transformed 
into S. aureus RN422020 and selected as chloramphenicol-resistant colonies, then the resulting modified plas-
mids were isolated and electroporated into S. aureus MW2 and N315. S. aureus was grown as described in the 
growth conditions. Bacterial cells from overnight cultures were washed with phosphate-buffered saline (PBS) and 
re-suspended to an optical density at 660 nm of 0.2. The cell suspension was then dispensed into triplicate wells 
(100 µl/well) of a U-bottom 96 well cell culture plate (Greiner Bio-One). The fluorescence intensity was measured 
using a Varioskan Flash Multimode Reader (ThermoFisher Scientific Inc.) with two independent samples.
Quantification of fluorescent proteins using SDS-PAGE and Western blot analysis. Fluorescent 
proteins were detected from whole cell lysates. S. aureus was cultured overnight as described in the growth con-
ditions. The pre-cultured cells were adjusted to an optical density at 660 nm of 0.02 with TSB with chloramphen-
icol, and 3 ml of the culture were transferred into test tube (25 mm × 150 mm) and then incubated at 37 °C with 
shaking at 140 rpm for 16 h. The bacterial cells from 1 ml cultures were harvested by centrifugation, and then 
the whole cell lysates were prepared as follows: cells were re-suspended in 200 μl CS buffer (100 mM Tris-HCI, 






−, ϕ80dlacZΔM15, Δ(lacZYA−argF)U169, deoR, recA1, endA1, hsdR17(rk−, mk+), phoA, 
supE44, λ−, thi-1, gyrA96, relA1 TaKaRa
S. aureus
 RN4220 NCTC8325-4, r- m+ 20
 N315 hospital-aquired MRSA 25
 MW2 community-aquired MRSA 26
 TY34 clinical isolate MRSA from patient with impetigo 35
Plasmids
 pMK4 Shuttle vector between E. coli and S. aureus, Amr in E. coli, Cmr in S. aureus 46
 pS1GFP pMK4 containing GFPmut3b gene fused to the blaZp promoter 19
 pND50 Shuttle vector between E. coli and S. aureus, Cmr 44
 pKAT pND50 derivative containing the lacZ(α) gene from pUC19, Cmr 43
 pAmCyan Plasmid encoding AmCyan gene, Ampr TaKaRa Clontech
 pmCherry Plasmid encoding mCherry gene, Ampr TaKaRa Clontech
 pFK51 pMK4 containing GFPmut3b gene fused to the blaZ/sodp promoter This study
 pFK52 pMK4 containing GFPsa gene fused to the blaZ/sodp promoter This study
 pFK53 pMK4 containing GFPmut3b gene fused to the blaZ/sodp(Con) promoter This study
 pFK54 pMK4 containing GFPsa gene fused to the blaZ/sodp(Con) promoter This study
 pFK55 pMK4 containing EGFP gene fused to the blaZ/sodp(Con) promoter This study
 pFK56 pMK4 containing Citrine gene fused to the blaZ/sodp(Con) promoter This study
 pFK57 pMK4 containing EBFP gene fused to the blaZ/sodp(Con) promoter This study
 pFK58 pMK4 containing BFP(P4-3E) gene fused to the blaZ/sodp(Con) promoter This study
 pFK59 pMK4 containing BFP(1EMF) gene fused to the blaZ/sodp(Con) promoter This study
 pFK60 pMK4 containing Cerulean gene fused to the blaZ/sodp(Con) promoter This study
 pFK61 pMK4 containing mEmerald gene fused to the blaZ/sodp(Con) promoter This study
 pFK62 pKAT containing AmCyan gene fused to the blaZ/sodp(Con) promoter This study
 pFK63 pKAT containing mCherry gene fused to the blaZ/sodp(Con) promoter This study
 pFK64 pKAT containing codon-optimized AmCyan(S.a) gene fused to the blaZ/sodp(Con) promoter This study
 pFK65 pKAT containing codon-optimized mCherry(S.a) gene fused to the blaZ/sodp(Con) promoter This study
Table 1. Bacterial strains and plasmids used in this study.
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Name primer sequence (5' to 3') Purpose
blaZPR AAATAATCATCCTCCTATTACAGTTGTAA replacement of RBS sequence
GFP-F ATGAGTAAAGGAGAAGAACTTTTCAC
blaZPmut-F TTTGTAAAAATATACACTTGAATAGGAGGATGAT destruction of BlaI motif
blaZPmut-R TCAATAATATTACCATTATGATATTGATG
F64LS65T-R TTGAACACCATATGTTAAAGTAGTAACAAG construction of Emerald and EGFP
F64LY66H-R TTGAACACCATGAGATAAAGTAGTAACAAG construction of BFP(P4-3E) and BFP(1EMF)
F64LS65TY66H-R TTGAACACCATGTGTTAATGTAGTAACAAG construction of EBFP
F64LS65TY66W-R TTGAACACCCCATGTTAAAGTAGTAACAAGTGTTG construction of Cerulean
S65GV68LQ69M-R CATTAAACCATAACCAAATGTAGTAACAAG construction of Citrine
S72-F TGTTTTTCAAGATATCCAGATCATATG construction of EGFP and BFP
S72A-F TGTTTTGCAAGATATCCAGATCATATG construction of Cerulean, Emerald, and Citrine
F99S-F TTCAAAGATGACGGTAACTACAAGAC construction of GFPsa
F99S-R AGATATAGTTCTTTCCTGTACATAACC construction of GFPsa
Y145F-R GATATATACATTATGTGAGTTAAAGTTATATTC construction of EBFP, P4-3E(BFP)
Y145AN146IH148D-R AATATATACATTGTCTGAGATAGCGTTATATTCCAA construction of Cerulean
N149KM153T-R CTTTTGTTTGTCTGCTGTAATATATACTTTATGTGAG construction of Emerald
I152-R AATATATACATTATGTGAATTATAGTTATATTCC construction of GFPsa and BFP(1EMF)
M153-F ATGGCAGACAAACAAAAGAATGGAATC construction of EBFP, P4-3E(BFP)
M153TV163A-F ACAGCAGACAAACAAAAGAATGGAATCAAAGCTAAC construction of GFPsa and Cerulean
V163A-F ATGGCAGACAAACAAAAGAATGGAATCAAAGCTAAC construction of 1EMF(BFP)
I167T-F AATGGAATTAAAGTTAACTTCAAAACAAGACAC construction of Emerald
T203Y-F TATCAATCTGCATTATCAAAAGATCCAAAC construction of Citrine
T203Y-R TGACAAATAATGATTGTCTGGTAAAAGAAC construction of Citrine
A206K-F ACACAATCTAAATTATCAAAAGATCCAAACG monomerization
gapRF AGAGAGGATCCTTAAATAGTTAGTTG amplification of gapR promoter
gapRGFPR GAAAAGTTCTTCTCCTTTACTCATTACTACCTCCTCCTTATATTTATA amplification of gapR promoter fused to GFP
gapRGFPF TATAAATATAAGGAGGAGGTAGTAATGAGTAAAGGAGAAGAACTTTTC amplification of gfp gene fused to gapR promoter
GFPRB GTCTAGATCTTTATTTGTATAGTTCATC amplification of gfp gene
blaZPF ACAAAAGCTTACTATGCTCATTATTAA amplification of blaZ gene promoter
blaZPR-Cyan AACTTGTTTGAAAGAGCCATAAATAATCATCCTCCTATTA amplification of blaZ gene promoter fused to AmCyan
blaZP-CyanF TAATAGGAGGATGATTATTTATGGCTCTTTCAAACAAGTT amplification of amCyan gene fused to blaZ promoter
blaZPR-mCherry TCCTCGCCCTTGCTCACCATAAATAATCATCCTTCCTATTA amplification of blaZ gene promoter fused to mCherry
blaZP-mCherryF TAATAGGAGGATGATTATTTATGGTGAGCAAGGGCGAGGA amplification of mCherry gene fused to blaZ promoter
pUC-RH AATGGAAGCTTCCGGCGCTCAGTTGG amplification of amCyan and mCherry
Cyan1F CATATGAAGGTACACAAACATCAACTTTTAAAGTTACAATGGCAAACGGTGGTCCACTTGCATTCTCATT codon optimization for amCyan
Cyan1R GTTTACCACTACCTTCACCTTTAACTGTAAAATAATGACCGTTAACACAACCATCCATATGATATGT
Cyan2F ATGCCAGATTATTTTAAACAAGCATTTCCTGATGGTATGTCATATGAACGTACTTTTACA codon optimization for amCyan
Cyan2R ACTTGTAGGATATGCAGTAAAACAACGATTACCATACATAAAAACTGTTGATAGAATAC
Cyan3F GAACATAAATCAACATTTCATGGAGTTAACTTTCC codon optimization for amCyan
Cyan3R AAAACAGTTACCTTTAAGACTTATTTCCCAACTTGC
Cyan4F CAAGGAGGTGGTAATTATAGATGTCAATTTCATACTTCTTATAAGACA codon optimization for amCyan
Cyan4R TAACATTAAAAATGCTGTAACATCACCCTTCAATATTCCATCACAAACAGTC
Cyan5F AAGGTGGTAATAGTGTTCAATTAACAGAACATGCTGTTGCACATATAACATCTGTTGTTCC codon optimization for amCyan
Cyan5R TATCTAAATCTGTTCTTGCAATACGATGTTCAACTGCATGGTTTGGTGGCATTGTAACTGGTTT
Cherry1F AGTTAATGGTCATGAATTCGAAATCGAGGGCGAGGGCGAGGGTCGTCCATATGAGGGCACACAAACAGC codon optimization for mCherry
Cherry1R GAACCTTCCATATGAACTTTAAAACGCATGAACTCCTTGATGATTGCCATGTTATCCTCCTCACCCTTAC
Cherry2F TATGGTTCAAAAGCATATGTTAAGCATCCAGCAGACATCCCAGACTATTTGAAGTTGTCATTCCCAGAGG codon optimization for mCherry
Cherry2R CATAAATTGAGGTGATAAGATGTCCCATGCGAATGGCAATGGACCACCCTTTGTCACCTTCAACTTTGC
Cherry3F TATTTATAAAGTTAAGTTGCGTGGTACAAACTTCCCATCAGACGGCCCAGTAATGCAGAAGAAGACAATG codon optimization for mCherry
Cherry3R AATTCACCATCTTGCAATGATGAGTCTTGTGTCACTGTAACCACACCGCCGTCCTCGAAGTTCATCACAC
Table 2. Oligonucleotide primers.
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150 mM NaCl, 100 mM EDTA, pH7.5) containing 1 μg of lysostaphin (Wako Pure Chemical Industries, Co., 
Ltd, Japan) and incubated at 37 °C for 30 min. Ten microliters of cell lysates were separated on SDS–PAGE and 
stained with Coomassie Brilliant Blue (CBB), and the fluorescent proteins were detected using Western blot with 
the following antibodies: Anti-GFP-HRP-Direct T (MBL Co., Ltd.), Living colors® Anti-RCFP Polyclonal Pan 
Antibody (Clontech Laboratories) and DsRed Polyclonal Antibody (Clontech Laboratories) as the primary anti-
body, and HRP-conjugated goat antibodies against rabbit IgG (MP Biomedicals, LLC-Cappel Products) as the 
secondary antibody. Immuno-detection of protein was performed on Pierce® Western Blot Substrate (Thermo 
Fisher Scientific Inc.) with X-ray film.
Confocal laser scanning microscopic analysis. S. aureus strains and E. coli were cultured in test tube 
(25 mm × 150 mm) containing 3 ml of Brain Heart Infusion (BHI) broth with chloramphenicol or ampicillin at 
37 °C with shaking at 140 rpm overnight. The pre-cultured cells were mixed and diluted 1:000 into 3 ml fresh 
BHI, and then incubated at 37 °C with shaking at 140 rpm for 6 h. Bacterial cells were harvested by centrifugation, 
washed twice with PBS buffer, fixed with 3% parafomaldehyde in PBS, and washed twice with PBS. Bacterial 
cells were counterstained with 0.1 μg/ml of 4′,6′-diamidino-2-phenylindole (DAPI) if necessary. The cell sus-
pensions were spotted onto glass slides and air-dried at room temperature. The coverslips were mounted using 
VECTASHIELD H-1000 (Vector Laboratories, Inc. Burlingame, CA). All confocal images were recorded using an 
confocal laser scanning microscopy (Olympus, Fluoview FV1000, Japan).
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